Medicure Inc. (CVE:MPH – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 606 shares trading hands. The stock had previously closed at C$0.83.
Medicure Stock Performance
The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of C$8.35 million, a price-to-earnings ratio of -3.20 and a beta of 0.90. The firm’s fifty day moving average price is C$0.89 and its 200 day moving average price is C$0.95.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Read More
- Five stocks we like better than Medicure
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- How to Invest in Small Cap Stocks
- How to Calculate Return on Investment (ROI)
- These Are the Dividend Stocks Insiders Bought in January
- What is a support level?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
